avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf1
|
ENSMUSG00000054191.10 | Klf1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf1 | mm39_v1_chr8_+_85628557_85628621 | 0.83 | 4.2e-10 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_109678685 | 26.62 |
ENSMUST00000112022.5
|
Camp
|
cathelicidin antimicrobial peptide |
chr7_-_103463120 | 19.80 |
ENSMUST00000098192.4
|
Hbb-bt
|
hemoglobin, beta adult t chain |
chr2_-_131001916 | 16.79 |
ENSMUST00000103188.10
ENSMUST00000133602.8 ENSMUST00000028800.12 |
1700037H04Rik
|
RIKEN cDNA 1700037H04 gene |
chr9_+_110848339 | 16.58 |
ENSMUST00000198884.5
ENSMUST00000196777.5 ENSMUST00000196209.5 ENSMUST00000035077.8 ENSMUST00000196122.3 |
Ltf
|
lactotransferrin |
chr8_+_85628557 | 15.65 |
ENSMUST00000067060.10
ENSMUST00000239392.2 |
Klf1
|
Kruppel-like factor 1 (erythroid) |
chr11_-_102255999 | 15.15 |
ENSMUST00000006749.10
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr6_-_72935171 | 13.90 |
ENSMUST00000114049.2
|
Tmsb10
|
thymosin, beta 10 |
chrX_-_7537580 | 13.83 |
ENSMUST00000033486.6
|
Plp2
|
proteolipid protein 2 |
chr6_-_72935468 | 13.54 |
ENSMUST00000114050.8
|
Tmsb10
|
thymosin, beta 10 |
chr7_-_126303351 | 13.11 |
ENSMUST00000106364.8
|
Coro1a
|
coronin, actin binding protein 1A |
chr14_+_80237691 | 13.03 |
ENSMUST00000228749.2
ENSMUST00000088735.4 |
Olfm4
|
olfactomedin 4 |
chr7_+_24069680 | 12.34 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr6_+_86605146 | 12.02 |
ENSMUST00000043400.9
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr9_-_44253588 | 11.99 |
ENSMUST00000215091.2
|
Hmbs
|
hydroxymethylbilane synthase |
chr12_-_4891435 | 11.79 |
ENSMUST00000219880.2
ENSMUST00000020964.7 |
Fkbp1b
|
FK506 binding protein 1b |
chr17_-_26420300 | 11.69 |
ENSMUST00000025019.9
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr7_-_24459736 | 11.49 |
ENSMUST00000063956.7
|
Cd177
|
CD177 antigen |
chr17_-_26161797 | 11.48 |
ENSMUST00000208043.2
ENSMUST00000148382.2 ENSMUST00000145745.3 |
Pigq
|
phosphatidylinositol glycan anchor biosynthesis, class Q |
chr15_+_78810919 | 11.34 |
ENSMUST00000089377.6
|
Lgals1
|
lectin, galactose binding, soluble 1 |
chr12_-_32111214 | 11.17 |
ENSMUST00000003079.12
ENSMUST00000036497.16 |
Prkar2b
|
protein kinase, cAMP dependent regulatory, type II beta |
chr7_-_103477126 | 10.89 |
ENSMUST00000023934.8
|
Hbb-bs
|
hemoglobin, beta adult s chain |
chr14_-_70867588 | 10.87 |
ENSMUST00000228009.2
|
Dmtn
|
dematin actin binding protein |
chr6_-_72935382 | 10.80 |
ENSMUST00000144337.2
|
Tmsb10
|
thymosin, beta 10 |
chrX_-_7834057 | 10.79 |
ENSMUST00000033502.14
|
Gata1
|
GATA binding protein 1 |
chr10_+_75784126 | 10.77 |
ENSMUST00000000926.3
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr6_+_86055018 | 9.87 |
ENSMUST00000205034.3
ENSMUST00000203724.3 |
Add2
|
adducin 2 (beta) |
chr7_-_142223662 | 9.79 |
ENSMUST00000228850.2
|
Gm49394
|
predicted gene, 49394 |
chr6_+_72526236 | 9.69 |
ENSMUST00000114071.8
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr5_-_134944366 | 9.66 |
ENSMUST00000008987.5
|
Cldn13
|
claudin 13 |
chr11_+_61967821 | 9.55 |
ENSMUST00000092415.9
ENSMUST00000201015.4 ENSMUST00000202744.4 ENSMUST00000201723.4 ENSMUST00000202179.2 |
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr10_-_81335966 | 9.43 |
ENSMUST00000053646.7
|
S1pr4
|
sphingosine-1-phosphate receptor 4 |
chr17_+_48606948 | 9.37 |
ENSMUST00000233092.2
|
Treml2
|
triggering receptor expressed on myeloid cells-like 2 |
chr7_-_126303689 | 9.27 |
ENSMUST00000135087.8
|
Coro1a
|
coronin, actin binding protein 1A |
chr7_-_16796309 | 9.01 |
ENSMUST00000153833.2
ENSMUST00000108492.9 |
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr7_-_37806912 | 8.96 |
ENSMUST00000108023.10
|
Ccne1
|
cyclin E1 |
chr14_-_70866385 | 8.93 |
ENSMUST00000228824.2
|
Dmtn
|
dematin actin binding protein |
chr19_+_10019023 | 8.76 |
ENSMUST00000237672.2
|
Fads3
|
fatty acid desaturase 3 |
chr11_+_120839288 | 8.74 |
ENSMUST00000070653.13
|
Slc16a3
|
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
chr14_+_56003406 | 8.70 |
ENSMUST00000057569.4
|
Ltb4r1
|
leukotriene B4 receptor 1 |
chr11_-_11987391 | 8.67 |
ENSMUST00000093321.12
|
Grb10
|
growth factor receptor bound protein 10 |
chr14_-_70864448 | 8.46 |
ENSMUST00000110984.4
|
Dmtn
|
dematin actin binding protein |
chr9_-_44253630 | 8.44 |
ENSMUST00000097558.5
|
Hmbs
|
hydroxymethylbilane synthase |
chr9_+_69361348 | 8.42 |
ENSMUST00000134907.8
|
Anxa2
|
annexin A2 |
chr3_+_90520408 | 8.26 |
ENSMUST00000198128.2
|
S100a6
|
S100 calcium binding protein A6 (calcyclin) |
chr2_+_162896602 | 8.19 |
ENSMUST00000018005.10
|
Mybl2
|
myeloblastosis oncogene-like 2 |
chr8_-_72178340 | 8.15 |
ENSMUST00000153800.8
ENSMUST00000146100.8 |
Fcho1
|
FCH domain only 1 |
chr9_+_69360902 | 8.09 |
ENSMUST00000034756.15
ENSMUST00000123470.8 |
Anxa2
|
annexin A2 |
chr7_-_140597837 | 8.06 |
ENSMUST00000209328.2
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr6_+_86055048 | 7.97 |
ENSMUST00000032069.8
|
Add2
|
adducin 2 (beta) |
chr6_-_39397334 | 7.84 |
ENSMUST00000031985.13
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr15_+_79975520 | 7.72 |
ENSMUST00000009728.13
ENSMUST00000009727.12 |
Syngr1
|
synaptogyrin 1 |
chr5_-_139311371 | 7.56 |
ENSMUST00000110865.2
|
Adap1
|
ArfGAP with dual PH domains 1 |
chr19_-_6065872 | 7.54 |
ENSMUST00000164843.10
|
Capn1
|
calpain 1 |
chr11_-_115968745 | 7.50 |
ENSMUST00000156545.2
ENSMUST00000075036.9 ENSMUST00000106451.8 |
Unc13d
|
unc-13 homolog D |
chr5_+_35106778 | 7.47 |
ENSMUST00000030984.14
|
Rgs12
|
regulator of G-protein signaling 12 |
chr9_+_54606144 | 7.45 |
ENSMUST00000120452.8
|
Dnaja4
|
DnaJ heat shock protein family (Hsp40) member A4 |
chr5_+_34731087 | 7.43 |
ENSMUST00000147574.8
ENSMUST00000146295.8 |
Add1
|
adducin 1 (alpha) |
chr7_+_126690525 | 7.42 |
ENSMUST00000056288.7
ENSMUST00000206102.2 |
AI467606
|
expressed sequence AI467606 |
chr5_+_34731152 | 7.36 |
ENSMUST00000001108.11
ENSMUST00000114340.9 |
Add1
|
adducin 1 (alpha) |
chr5_+_34731008 | 7.34 |
ENSMUST00000114338.9
|
Add1
|
adducin 1 (alpha) |
chr7_-_140597465 | 7.34 |
ENSMUST00000211330.2
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chrX_-_73289970 | 7.33 |
ENSMUST00000130007.8
|
Flna
|
filamin, alpha |
chr4_-_43045685 | 7.28 |
ENSMUST00000107956.8
ENSMUST00000107957.8 |
Fam214b
|
family with sequence similarity 214, member B |
chr7_+_100145192 | 7.26 |
ENSMUST00000133044.3
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr7_-_126399208 | 7.24 |
ENSMUST00000133514.8
ENSMUST00000151137.8 |
Aldoa
|
aldolase A, fructose-bisphosphate |
chr7_-_126399574 | 7.19 |
ENSMUST00000106348.8
|
Aldoa
|
aldolase A, fructose-bisphosphate |
chr15_-_79976016 | 7.19 |
ENSMUST00000185306.3
|
Rpl3
|
ribosomal protein L3 |
chr11_-_115968373 | 7.17 |
ENSMUST00000174822.8
|
Unc13d
|
unc-13 homolog D |
chrX_-_73290140 | 7.16 |
ENSMUST00000101454.9
ENSMUST00000033699.13 |
Flna
|
filamin, alpha |
chr4_+_134195631 | 7.11 |
ENSMUST00000030636.11
ENSMUST00000127279.8 ENSMUST00000105867.8 |
Stmn1
|
stathmin 1 |
chr1_+_170472092 | 7.09 |
ENSMUST00000046792.9
|
Olfml2b
|
olfactomedin-like 2B |
chr11_+_11634967 | 7.09 |
ENSMUST00000141436.8
ENSMUST00000126058.8 |
Ikzf1
|
IKAROS family zinc finger 1 |
chr17_+_36172210 | 6.99 |
ENSMUST00000074259.15
ENSMUST00000174873.2 |
Nrm
|
nurim (nuclear envelope membrane protein) |
chr17_+_41121979 | 6.95 |
ENSMUST00000024721.8
ENSMUST00000233740.2 |
Rhag
|
Rhesus blood group-associated A glycoprotein |
chr7_-_126399778 | 6.91 |
ENSMUST00000141355.4
|
Aldoa
|
aldolase A, fructose-bisphosphate |
chr11_+_62466851 | 6.89 |
ENSMUST00000102643.2
|
Trpv2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr8_+_85449632 | 6.88 |
ENSMUST00000098571.5
|
G430095P16Rik
|
RIKEN cDNA G430095P16 gene |
chr17_-_35285146 | 6.85 |
ENSMUST00000174190.2
ENSMUST00000097337.8 |
Mpig6b
|
megakaryocyte and platelet inhibitory receptor G6b |
chr2_+_131028861 | 6.84 |
ENSMUST00000028804.15
ENSMUST00000079857.9 |
Cdc25b
|
cell division cycle 25B |
chr14_-_70855980 | 6.84 |
ENSMUST00000228001.2
|
Dmtn
|
dematin actin binding protein |
chr11_+_32226400 | 6.82 |
ENSMUST00000020531.9
|
Hba-x
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
chrX_-_149595873 | 6.80 |
ENSMUST00000131241.2
ENSMUST00000147152.3 ENSMUST00000143843.8 |
Maged2
|
MAGE family member D2 |
chr6_-_39397212 | 6.77 |
ENSMUST00000114822.2
ENSMUST00000051671.11 |
Mkrn1
|
makorin, ring finger protein, 1 |
chrX_-_135116192 | 6.68 |
ENSMUST00000113120.2
ENSMUST00000113118.2 ENSMUST00000058125.9 |
Bex1
|
brain expressed X-linked 1 |
chr9_-_107863062 | 6.64 |
ENSMUST00000048568.6
|
Inka1
|
inka box actin regulator 1 |
chrX_+_8137372 | 6.62 |
ENSMUST00000127103.8
ENSMUST00000115591.8 |
Slc38a5
|
solute carrier family 38, member 5 |
chr17_+_37180437 | 6.60 |
ENSMUST00000060524.11
|
Trim10
|
tripartite motif-containing 10 |
chr10_-_84369831 | 6.59 |
ENSMUST00000167671.2
ENSMUST00000053871.5 |
Ckap4
|
cytoskeleton-associated protein 4 |
chr13_+_54849268 | 6.55 |
ENSMUST00000037145.8
|
Cdhr2
|
cadherin-related family member 2 |
chr6_+_72526414 | 6.51 |
ENSMUST00000155705.8
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr11_+_58165625 | 6.49 |
ENSMUST00000108834.3
|
4930438A08Rik
|
RIKEN cDNA 4930438A08 gene |
chr9_-_114610879 | 6.48 |
ENSMUST00000084867.9
ENSMUST00000216760.2 ENSMUST00000035009.16 |
Cmtm7
|
CKLF-like MARVEL transmembrane domain containing 7 |
chr17_-_26420332 | 6.43 |
ENSMUST00000121959.3
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr7_-_80453033 | 6.41 |
ENSMUST00000167377.3
|
Iqgap1
|
IQ motif containing GTPase activating protein 1 |
chr4_-_41098174 | 6.41 |
ENSMUST00000055327.8
|
Aqp3
|
aquaporin 3 |
chr10_-_128237087 | 6.28 |
ENSMUST00000042666.13
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr9_+_119943916 | 6.27 |
ENSMUST00000135514.2
|
Slc25a38
|
solute carrier family 25, member 38 |
chr7_+_100142977 | 6.23 |
ENSMUST00000129324.8
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr7_-_142209755 | 6.21 |
ENSMUST00000178921.2
|
Igf2
|
insulin-like growth factor 2 |
chr6_+_72526635 | 6.19 |
ENSMUST00000134809.8
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr14_+_30930266 | 6.18 |
ENSMUST00000169169.8
|
Tnnc1
|
troponin C, cardiac/slow skeletal |
chr7_-_135318074 | 6.16 |
ENSMUST00000033310.9
|
Mki67
|
antigen identified by monoclonal antibody Ki 67 |
chr7_+_78563964 | 6.15 |
ENSMUST00000120331.4
|
Isg20
|
interferon-stimulated protein |
chr7_+_142559414 | 6.13 |
ENSMUST00000082008.12
ENSMUST00000105925.8 ENSMUST00000105924.8 |
Tspan32
|
tetraspanin 32 |
chr9_+_56344700 | 6.11 |
ENSMUST00000239472.2
|
ENSMUSG00000118653.2
|
ubiquitin-conjugating enzyme E2S (Ube2s) retrogene |
chr7_-_97827461 | 6.11 |
ENSMUST00000040971.14
|
Capn5
|
calpain 5 |
chr17_+_29042640 | 6.10 |
ENSMUST00000233088.2
ENSMUST00000233182.2 ENSMUST00000233520.2 |
Brpf3
|
bromodomain and PHD finger containing, 3 |
chr7_-_140596811 | 6.09 |
ENSMUST00000081924.5
|
Ifitm6
|
interferon induced transmembrane protein 6 |
chr13_+_45660905 | 6.06 |
ENSMUST00000000260.13
|
Gmpr
|
guanosine monophosphate reductase |
chr4_-_133856025 | 6.02 |
ENSMUST00000105879.2
ENSMUST00000030651.9 |
Sh3bgrl3
|
SH3 domain binding glutamic acid-rich protein-like 3 |
chr2_-_181335697 | 6.01 |
ENSMUST00000108779.8
ENSMUST00000108769.8 ENSMUST00000108772.8 |
Rgs19
|
regulator of G-protein signaling 19 |
chr13_+_55593116 | 5.98 |
ENSMUST00000001115.16
ENSMUST00000224995.2 ENSMUST00000225925.2 ENSMUST00000099482.5 ENSMUST00000224118.2 |
Grk6
|
G protein-coupled receptor kinase 6 |
chr2_+_125089110 | 5.97 |
ENSMUST00000082122.14
|
Dut
|
deoxyuridine triphosphatase |
chr5_+_123214332 | 5.95 |
ENSMUST00000067505.15
ENSMUST00000111619.10 ENSMUST00000160344.2 |
Tmem120b
|
transmembrane protein 120B |
chr4_+_120523758 | 5.94 |
ENSMUST00000094814.6
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr19_-_6065415 | 5.89 |
ENSMUST00000237519.2
|
Capn1
|
calpain 1 |
chr4_-_43040278 | 5.84 |
ENSMUST00000107958.8
ENSMUST00000107959.8 ENSMUST00000152846.8 |
Fam214b
|
family with sequence similarity 214, member B |
chr7_-_4755971 | 5.76 |
ENSMUST00000183971.8
ENSMUST00000182173.2 ENSMUST00000182738.8 ENSMUST00000182111.8 ENSMUST00000184143.8 ENSMUST00000182048.2 ENSMUST00000063324.14 |
Cox6b2
|
cytochrome c oxidase subunit 6B2 |
chr3_+_108291145 | 5.75 |
ENSMUST00000090561.10
ENSMUST00000102629.8 ENSMUST00000128089.2 |
Psrc1
|
proline/serine-rich coiled-coil 1 |
chr7_-_143056252 | 5.69 |
ENSMUST00000010904.5
|
Phlda2
|
pleckstrin homology like domain, family A, member 2 |
chr10_-_12839995 | 5.67 |
ENSMUST00000219727.2
ENSMUST00000163425.9 ENSMUST00000042861.7 ENSMUST00000218685.2 |
Stx11
|
syntaxin 11 |
chr10_-_128236317 | 5.58 |
ENSMUST00000167859.2
ENSMUST00000218858.2 |
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr19_-_20368029 | 5.56 |
ENSMUST00000235280.2
|
Anxa1
|
annexin A1 |
chrX_+_70600481 | 5.50 |
ENSMUST00000123100.2
|
Hmgb3
|
high mobility group box 3 |
chr17_-_7050145 | 5.45 |
ENSMUST00000064234.7
|
Ezr
|
ezrin |
chr7_+_142559375 | 5.44 |
ENSMUST00000075172.12
ENSMUST00000105923.8 |
Tspan32
|
tetraspanin 32 |
chr14_-_60324265 | 5.43 |
ENSMUST00000080368.13
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr11_-_102360664 | 5.43 |
ENSMUST00000103086.4
|
Itga2b
|
integrin alpha 2b |
chr7_+_13012735 | 5.41 |
ENSMUST00000098814.13
ENSMUST00000146998.9 |
Lig1
|
ligase I, DNA, ATP-dependent |
chr10_+_3923086 | 5.40 |
ENSMUST00000117291.8
ENSMUST00000120585.8 ENSMUST00000043735.8 |
Mthfd1l
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chrX_+_8137620 | 5.31 |
ENSMUST00000033512.11
|
Slc38a5
|
solute carrier family 38, member 5 |
chr7_-_126302315 | 5.31 |
ENSMUST00000173108.8
ENSMUST00000205515.2 |
Coro1a
|
coronin, actin binding protein 1A |
chr1_-_167221344 | 5.29 |
ENSMUST00000028005.3
|
Mgst3
|
microsomal glutathione S-transferase 3 |
chr5_-_134258435 | 5.24 |
ENSMUST00000016094.13
ENSMUST00000111275.8 ENSMUST00000144086.2 |
Ncf1
|
neutrophil cytosolic factor 1 |
chr11_-_84719779 | 5.23 |
ENSMUST00000047560.8
|
Dhrs11
|
dehydrogenase/reductase (SDR family) member 11 |
chr2_+_154633265 | 5.20 |
ENSMUST00000140713.3
ENSMUST00000137333.8 |
Raly
a
|
hnRNP-associated with lethal yellow nonagouti |
chr11_+_32226893 | 5.18 |
ENSMUST00000145569.2
|
Hba-x
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
chrX_-_74174450 | 5.17 |
ENSMUST00000114092.8
ENSMUST00000132501.8 ENSMUST00000153318.8 ENSMUST00000155742.2 |
Mpp1
|
membrane protein, palmitoylated |
chr10_-_81214293 | 5.15 |
ENSMUST00000140901.8
|
Fzr1
|
fizzy and cell division cycle 20 related 1 |
chr15_+_73620213 | 5.11 |
ENSMUST00000053232.8
|
Ptp4a3
|
protein tyrosine phosphatase 4a3 |
chr19_+_10018914 | 5.06 |
ENSMUST00000115995.4
|
Fads3
|
fatty acid desaturase 3 |
chr2_-_163760603 | 5.04 |
ENSMUST00000044734.3
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr2_+_29759495 | 5.02 |
ENSMUST00000047521.7
ENSMUST00000134152.2 |
Cercam
|
cerebral endothelial cell adhesion molecule |
chr8_-_106198112 | 5.02 |
ENSMUST00000014990.13
|
Tppp3
|
tubulin polymerization-promoting protein family member 3 |
chr11_-_115968576 | 5.02 |
ENSMUST00000106450.8
|
Unc13d
|
unc-13 homolog D |
chrX_+_72683020 | 5.01 |
ENSMUST00000019701.9
|
Dusp9
|
dual specificity phosphatase 9 |
chr15_-_103161237 | 4.99 |
ENSMUST00000154510.8
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr13_-_74085880 | 4.96 |
ENSMUST00000022053.11
|
Trip13
|
thyroid hormone receptor interactor 13 |
chr8_+_86026318 | 4.93 |
ENSMUST00000170141.3
ENSMUST00000034132.13 |
Orc6
|
origin recognition complex, subunit 6 |
chr9_-_21202353 | 4.93 |
ENSMUST00000086374.8
|
Cdkn2d
|
cyclin dependent kinase inhibitor 2D |
chr6_-_39396902 | 4.93 |
ENSMUST00000122996.8
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr2_+_24275321 | 4.93 |
ENSMUST00000056641.15
ENSMUST00000142522.8 ENSMUST00000131930.2 |
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr4_+_108436639 | 4.92 |
ENSMUST00000102744.4
|
Orc1
|
origin recognition complex, subunit 1 |
chr13_-_100922910 | 4.92 |
ENSMUST00000174038.2
ENSMUST00000091295.14 ENSMUST00000072119.15 |
Ccnb1
|
cyclin B1 |
chr17_+_29042544 | 4.87 |
ENSMUST00000140587.9
|
Brpf3
|
bromodomain and PHD finger containing, 3 |
chrX_+_135039745 | 4.86 |
ENSMUST00000116527.2
|
Bex4
|
brain expressed X-linked 4 |
chr7_-_126625617 | 4.83 |
ENSMUST00000032916.6
|
Maz
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr2_-_164197987 | 4.83 |
ENSMUST00000165980.2
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr4_-_106321363 | 4.81 |
ENSMUST00000049507.6
|
Pcsk9
|
proprotein convertase subtilisin/kexin type 9 |
chr2_-_164198427 | 4.81 |
ENSMUST00000109367.10
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr19_+_8944369 | 4.80 |
ENSMUST00000052248.8
|
Eef1g
|
eukaryotic translation elongation factor 1 gamma |
chr4_-_152533265 | 4.80 |
ENSMUST00000159840.8
ENSMUST00000105648.10 |
Kcnab2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr7_+_78564062 | 4.79 |
ENSMUST00000205981.2
|
Isg20
|
interferon-stimulated protein |
chr4_-_131802561 | 4.78 |
ENSMUST00000105970.8
ENSMUST00000105975.8 |
Epb41
|
erythrocyte membrane protein band 4.1 |
chr4_-_43046196 | 4.77 |
ENSMUST00000036462.12
|
Fam214b
|
family with sequence similarity 214, member B |
chr2_+_174292471 | 4.77 |
ENSMUST00000016399.6
|
Tubb1
|
tubulin, beta 1 class VI |
chr9_-_107512511 | 4.76 |
ENSMUST00000192615.6
ENSMUST00000192837.2 ENSMUST00000193876.2 |
Gnai2
|
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
chr10_+_79855454 | 4.76 |
ENSMUST00000043311.7
|
Arhgap45
|
Rho GTPase activating protein 45 |
chr18_-_43870622 | 4.75 |
ENSMUST00000025381.4
|
Spink1
|
serine peptidase inhibitor, Kazal type 1 |
chr7_-_126736979 | 4.73 |
ENSMUST00000049931.6
|
Spn
|
sialophorin |
chr7_-_4815111 | 4.72 |
ENSMUST00000205885.2
|
Ube2s
|
ubiquitin-conjugating enzyme E2S |
chr2_+_131333800 | 4.71 |
ENSMUST00000110179.9
ENSMUST00000110189.9 ENSMUST00000110182.9 ENSMUST00000110183.9 ENSMUST00000110186.9 ENSMUST00000110188.8 |
Smox
|
spermine oxidase |
chrX_+_20554618 | 4.70 |
ENSMUST00000033380.7
|
Cdk16
|
cyclin-dependent kinase 16 |
chr17_+_29709723 | 4.70 |
ENSMUST00000024811.9
|
Pim1
|
proviral integration site 1 |
chr8_+_111646548 | 4.69 |
ENSMUST00000117534.8
ENSMUST00000034197.5 |
St3gal2
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
chr6_-_83294526 | 4.67 |
ENSMUST00000005810.9
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
chr2_-_181335518 | 4.63 |
ENSMUST00000108776.8
ENSMUST00000108771.2 |
Rgs19
|
regulator of G-protein signaling 19 |
chr14_-_70864666 | 4.60 |
ENSMUST00000022694.17
|
Dmtn
|
dematin actin binding protein |
chr4_-_41314877 | 4.56 |
ENSMUST00000030145.9
|
Dcaf12
|
DDB1 and CUL4 associated factor 12 |
chr18_-_42084249 | 4.55 |
ENSMUST00000070949.6
ENSMUST00000235606.2 |
Prelid2
|
PRELI domain containing 2 |
chr17_+_47908025 | 4.47 |
ENSMUST00000183206.2
|
Ccnd3
|
cyclin D3 |
chr17_+_48623157 | 4.46 |
ENSMUST00000049614.13
|
B430306N03Rik
|
RIKEN cDNA B430306N03 gene |
chr11_+_97340962 | 4.45 |
ENSMUST00000107601.8
|
Arhgap23
|
Rho GTPase activating protein 23 |
chr4_-_41275091 | 4.43 |
ENSMUST00000030143.13
ENSMUST00000108068.8 |
Ubap2
|
ubiquitin-associated protein 2 |
chrX_-_149595711 | 4.43 |
ENSMUST00000112697.10
|
Maged2
|
MAGE family member D2 |
chr17_+_36176485 | 4.41 |
ENSMUST00000127442.8
ENSMUST00000144382.8 |
Ppp1r18
|
protein phosphatase 1, regulatory subunit 18 |
chr1_+_39407183 | 4.40 |
ENSMUST00000195123.6
|
Rpl31
|
ribosomal protein L31 |
chr17_+_33848054 | 4.38 |
ENSMUST00000166627.8
ENSMUST00000073570.12 ENSMUST00000170225.3 |
Zfp414
|
zinc finger protein 414 |
chr7_-_126625657 | 4.35 |
ENSMUST00000205568.2
|
Maz
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr7_+_100142544 | 4.34 |
ENSMUST00000126534.8
ENSMUST00000207748.2 |
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr11_-_16958647 | 4.33 |
ENSMUST00000102881.10
|
Plek
|
pleckstrin |
chr15_+_82225380 | 4.30 |
ENSMUST00000050349.3
|
Pheta2
|
PH domain containing endocytic trafficking adaptor 2 |
chr16_+_32427738 | 4.27 |
ENSMUST00000023486.15
|
Tfrc
|
transferrin receptor |
chr17_+_35268942 | 4.25 |
ENSMUST00000007257.10
|
Clic1
|
chloride intracellular channel 1 |
chr8_+_57964921 | 4.25 |
ENSMUST00000067925.8
|
Hmgb2
|
high mobility group box 2 |
chr5_+_137628377 | 4.24 |
ENSMUST00000175968.8
|
Lrch4
|
leucine-rich repeats and calponin homology (CH) domain containing 4 |
chr7_-_80037622 | 4.24 |
ENSMUST00000206698.2
|
Fes
|
feline sarcoma oncogene |
chr8_+_85696396 | 4.23 |
ENSMUST00000109733.8
|
Prdx2
|
peroxiredoxin 2 |
chr9_-_107512566 | 4.22 |
ENSMUST00000055704.12
|
Gnai2
|
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
chr12_-_113386312 | 4.20 |
ENSMUST00000177715.8
ENSMUST00000103426.3 |
Ighm
|
immunoglobulin heavy constant mu |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.4 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
6.6 | 39.7 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
4.8 | 14.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
4.1 | 16.6 | GO:0044407 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) membrane disruption in other organism(GO:0051673) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
3.8 | 11.3 | GO:0034118 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
3.8 | 30.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
3.6 | 10.8 | GO:0030221 | basophil differentiation(GO:0030221) |
2.8 | 8.4 | GO:0010924 | regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010924) positive regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010925) phospholipase C-inhibiting G-protein coupled receptor signaling pathway(GO:0030845) regulation of cell diameter(GO:0060305) |
2.8 | 16.5 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
2.5 | 19.7 | GO:0002432 | granuloma formation(GO:0002432) |
2.5 | 4.9 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
2.4 | 9.7 | GO:0015904 | tetracycline transport(GO:0015904) |
2.4 | 21.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.4 | 7.1 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
2.2 | 26.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
2.2 | 6.5 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
2.1 | 4.2 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
2.1 | 23.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.1 | 6.2 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
2.1 | 6.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.0 | 7.8 | GO:0015793 | glycerol transport(GO:0015793) |
1.9 | 9.6 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.9 | 5.7 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
1.9 | 7.4 | GO:1902896 | terminal web assembly(GO:1902896) |
1.8 | 7.4 | GO:0045399 | regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) cellular response to molecule of fungal origin(GO:0071226) |
1.8 | 10.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.8 | 7.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.8 | 14.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.7 | 5.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.7 | 7.0 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
1.7 | 7.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.7 | 6.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.7 | 5.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.7 | 6.6 | GO:0010286 | heat acclimation(GO:0010286) |
1.6 | 4.9 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.6 | 6.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.6 | 8.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.6 | 4.7 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.6 | 31.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.6 | 1.6 | GO:0051383 | kinetochore organization(GO:0051383) |
1.6 | 6.3 | GO:0036233 | glycine import(GO:0036233) |
1.5 | 6.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.5 | 4.6 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.5 | 25.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.5 | 7.5 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.5 | 6.0 | GO:0009223 | dUMP biosynthetic process(GO:0006226) pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
1.5 | 51.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.4 | 5.8 | GO:0046083 | adenine salvage(GO:0006168) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.4 | 5.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.4 | 27.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.4 | 26.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.4 | 8.5 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.4 | 7.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
1.4 | 4.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.4 | 2.8 | GO:0071611 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
1.4 | 5.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
1.3 | 8.1 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
1.3 | 2.6 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.3 | 5.2 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
1.3 | 14.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.3 | 5.2 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
1.3 | 3.9 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.3 | 3.9 | GO:0002215 | defense response to nematode(GO:0002215) |
1.3 | 1.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.3 | 3.9 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.3 | 12.8 | GO:0019659 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.3 | 2.5 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
1.2 | 3.7 | GO:0051329 | interphase(GO:0051325) mitotic interphase(GO:0051329) |
1.2 | 11.1 | GO:0007144 | female meiosis I(GO:0007144) |
1.2 | 3.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.2 | 6.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.2 | 4.8 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
1.2 | 3.6 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
1.2 | 5.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.2 | 3.6 | GO:1900239 | regulation of phenotypic switching(GO:1900239) |
1.2 | 3.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
1.1 | 5.7 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
1.1 | 17.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.1 | 2.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.1 | 5.6 | GO:0097350 | neutrophil clearance(GO:0097350) |
1.1 | 3.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.1 | 3.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.0 | 3.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.0 | 7.1 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.0 | 4.0 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
1.0 | 5.0 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.0 | 4.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.0 | 1.0 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.0 | 2.9 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
1.0 | 11.6 | GO:0015816 | glycine transport(GO:0015816) |
1.0 | 2.9 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.9 | 5.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.9 | 2.8 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.9 | 5.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.9 | 5.5 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.9 | 10.6 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.9 | 6.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.9 | 3.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.9 | 3.5 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.9 | 8.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.9 | 2.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.9 | 6.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 8.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.8 | 6.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.8 | 4.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.8 | 4.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 2.4 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.8 | 0.8 | GO:0006971 | hypotonic response(GO:0006971) |
0.8 | 2.4 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.8 | 1.6 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.8 | 9.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.8 | 6.8 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.8 | 6.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 5.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.7 | 7.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.7 | 6.0 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.7 | 2.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.7 | 2.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.7 | 2.9 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.7 | 8.7 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.7 | 5.0 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.7 | 5.7 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.7 | 16.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.7 | 2.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.7 | 3.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.7 | 2.6 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.7 | 0.7 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.6 | 3.9 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.6 | 6.4 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.6 | 8.8 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.6 | 2.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.6 | 9.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.6 | 2.4 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
0.6 | 1.8 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.6 | 3.6 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.6 | 10.7 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.6 | 1.8 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
0.6 | 3.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.6 | 1.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.6 | 6.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.6 | 2.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.6 | 1.7 | GO:0097045 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
0.6 | 23.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.6 | 4.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.6 | 1.7 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.6 | 1.7 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.5 | 3.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.5 | 2.7 | GO:0002339 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) |
0.5 | 1.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 1.6 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.5 | 2.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.5 | 1.6 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.5 | 4.7 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.5 | 3.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 3.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.5 | 1.6 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.5 | 2.0 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.5 | 10.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 3.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.5 | 1.5 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.5 | 2.5 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.5 | 4.5 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.5 | 4.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 1.5 | GO:0010652 | atrial ventricular junction remodeling(GO:0003294) regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.5 | 1.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 1.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 15.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.5 | 2.9 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 1.9 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) sodium-dependent self proteolysis(GO:1990091) |
0.5 | 2.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 2.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.5 | 11.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.5 | 1.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 2.8 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 3.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 3.2 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.5 | 1.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 4.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.4 | 1.3 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.4 | 1.8 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.4 | 1.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 2.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.4 | 4.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 3.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.4 | 3.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 5.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 1.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 2.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 0.4 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.4 | 9.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.4 | 2.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.4 | 4.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 5.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.4 | 0.8 | GO:0032796 | uropod organization(GO:0032796) |
0.4 | 1.6 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.4 | 2.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 11.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 1.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.4 | 2.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 2.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 1.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 2.6 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 5.6 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.4 | 1.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 1.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 11.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 8.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 0.7 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.4 | 1.4 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.4 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.4 | 0.7 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.4 | 3.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 1.4 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.4 | 1.4 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.3 | 1.4 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.3 | 1.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.3 | 1.0 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 | 2.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 2.0 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.3 | 1.0 | GO:0061723 | glycophagy(GO:0061723) |
0.3 | 12.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 2.0 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 5.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 1.0 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
0.3 | 1.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 6.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.9 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.3 | 11.0 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.3 | 3.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 7.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 1.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 1.2 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.3 | 1.9 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.3 | 6.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.3 | 10.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 2.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 1.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 1.2 | GO:0017126 | nucleologenesis(GO:0017126) |
0.3 | 2.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 4.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 1.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.3 | 0.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 14.8 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 5.8 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.3 | 2.9 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.3 | 2.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.3 | 2.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 2.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 0.8 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.3 | 1.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.3 | 1.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 7.2 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.3 | 0.8 | GO:1990428 | miRNA transport(GO:1990428) |
0.3 | 1.3 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 2.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 9.8 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.3 | 1.0 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.3 | 1.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 2.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 4.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.2 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.2 | 1.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 1.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.7 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.2 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 2.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.9 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 | 1.4 | GO:0060082 | response to carbon monoxide(GO:0034465) eye blink reflex(GO:0060082) |
0.2 | 0.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.2 | 1.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 6.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 4.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.2 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.2 | 1.8 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 1.1 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 1.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 2.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 1.9 | GO:0015879 | carnitine transport(GO:0015879) |
0.2 | 1.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 1.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 1.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.2 | 0.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 3.9 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 1.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 7.9 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 2.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 1.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 3.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 1.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 3.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.8 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.7 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 7.2 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.2 | 4.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 14.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 13.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.5 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.2 | 0.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 6.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.5 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 5.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.7 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.2 | 4.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.7 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 1.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.2 | 1.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 1.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 2.8 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.9 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 2.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 2.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 3.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 1.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.5 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.2 | 4.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 1.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 1.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 1.0 | GO:0046618 | xenobiotic transport(GO:0042908) drug export(GO:0046618) |
0.2 | 2.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 1.1 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 1.3 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 1.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.5 | GO:0046436 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.2 | 0.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 1.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 1.5 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 1.8 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 1.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 1.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 4.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.1 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
0.1 | 0.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 1.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.1 | 4.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 3.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 1.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.7 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 1.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 24.1 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 0.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 2.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 4.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 2.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 2.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 1.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 1.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.4 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.1 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 2.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 1.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 1.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 2.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 2.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 2.6 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 5.8 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.8 | GO:0043578 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 8.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.5 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 4.5 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 2.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.1 | 2.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.3 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.8 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 1.2 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 2.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 1.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.6 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.4 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.1 | 3.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 1.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 2.6 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 1.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 7.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 1.1 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 5.8 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 2.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 2.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 1.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 7.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 1.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 2.0 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.3 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 0.4 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.1 | 0.6 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 3.1 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 2.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 3.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.5 | GO:0050917 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.1 | 1.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 2.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 2.3 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.2 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 1.0 | GO:0015677 | copper ion import(GO:0015677) |
0.1 | 1.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.3 | GO:1901382 | transforming growth factor beta receptor complex assembly(GO:0007181) chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 1.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.4 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.7 | GO:0043314 | negative regulation of cellular extravasation(GO:0002692) negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.1 | 0.6 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 1.8 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.4 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 1.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 2.2 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 3.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.1 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.6 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 1.0 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 2.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.1 | 0.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.6 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 1.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.7 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.1 | 0.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 1.3 | GO:0045005 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 2.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.2 | GO:1904502 | sphinganine metabolic process(GO:0006667) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.9 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 1.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 1.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 1.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 1.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 1.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.6 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.0 | 1.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.8 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.0 | 1.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 1.2 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 1.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 1.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.5 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.5 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.3 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 0.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.7 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.0 | 0.3 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.6 | GO:0090189 | positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.0 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 1.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 2.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.4 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.0 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 1.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 1.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.5 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 3.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.2 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.0 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 1.6 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.0 | 0.4 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.0 | 0.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.4 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.5 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 1.1 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.5 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.2 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 1.2 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.0 | 0.2 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.0 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.5 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.4 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 1.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.4 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.2 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 1.0 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.0 | GO:0042694 | muscle cell fate specification(GO:0042694) |
0.0 | 0.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 21.3 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
6.1 | 30.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
5.9 | 41.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
3.8 | 22.7 | GO:0031523 | Myb complex(GO:0031523) |
3.4 | 10.2 | GO:1990031 | pinceau fiber(GO:1990031) |
3.0 | 15.2 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
3.0 | 12.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.8 | 42.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.8 | 16.6 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
1.9 | 5.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
1.8 | 5.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
1.7 | 37.1 | GO:0042581 | specific granule(GO:0042581) |
1.7 | 16.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.6 | 6.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.6 | 6.2 | GO:0001740 | Barr body(GO:0001740) |
1.5 | 4.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
1.4 | 23.8 | GO:0090543 | Flemming body(GO:0090543) |
1.3 | 8.1 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
1.3 | 11.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.3 | 3.9 | GO:1990879 | CST complex(GO:1990879) |
1.2 | 31.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
1.2 | 3.6 | GO:0060205 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
1.1 | 11.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.1 | 17.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.1 | 11.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.1 | 9.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.0 | 5.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
1.0 | 3.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.0 | 7.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.9 | 2.8 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.9 | 2.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.9 | 29.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.9 | 6.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.9 | 7.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.8 | 0.8 | GO:0019034 | viral replication complex(GO:0019034) |
0.8 | 4.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.8 | 2.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.8 | 2.3 | GO:0034455 | t-UTP complex(GO:0034455) |
0.7 | 9.0 | GO:0005861 | troponin complex(GO:0005861) |
0.7 | 8.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.7 | 3.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.7 | 1.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 2.1 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) cyclin K-CDK13 complex(GO:0002945) |
0.7 | 5.6 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.7 | 2.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.7 | 10.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 2.0 | GO:0031904 | endosome lumen(GO:0031904) |
0.6 | 6.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.6 | 11.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.6 | 5.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.6 | 6.8 | GO:0031415 | NatA complex(GO:0031415) |
0.6 | 9.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.6 | 1.8 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.6 | 1.8 | GO:0000811 | GINS complex(GO:0000811) |
0.6 | 1.8 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.6 | 2.3 | GO:0014802 | terminal cisterna(GO:0014802) |
0.6 | 18.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.6 | 2.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.6 | 1.1 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) extrinsic component of postsynaptic membrane(GO:0098890) |
0.5 | 2.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.5 | 3.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 5.5 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.5 | 10.9 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 7.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 3.3 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 1.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 4.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 3.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 7.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 4.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 19.1 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 28.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 11.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 4.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 1.8 | GO:0045160 | myosin I complex(GO:0045160) |
0.4 | 21.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 5.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 24.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 2.0 | GO:0070826 | paraferritin complex(GO:0070826) |
0.3 | 1.3 | GO:0035101 | FACT complex(GO:0035101) |
0.3 | 2.8 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 1.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 3.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 5.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.4 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.3 | 6.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.3 | 3.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 15.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 1.6 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.3 | 9.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 13.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 1.6 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.3 | 0.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 18.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 1.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 2.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 2.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 2.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 1.0 | GO:0071920 | cleavage body(GO:0071920) |
0.2 | 0.9 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 2.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.7 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 2.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 1.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 2.9 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 6.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 4.4 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.7 | GO:0097635 | extrinsic component of pre-autophagosomal structure membrane(GO:0097632) extrinsic component of autophagosome membrane(GO:0097635) |
0.2 | 0.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 2.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 8.3 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 1.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 3.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 1.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 3.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 1.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 5.2 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 25.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 0.9 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 2.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 2.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 2.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 2.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 5.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 8.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 4.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 9.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 7.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 2.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.5 | GO:0043512 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin A complex(GO:0043512) |
0.2 | 0.5 | GO:0097361 | CIA complex(GO:0097361) |
0.2 | 2.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 23.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 1.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 1.3 | GO:0070187 | telosome(GO:0070187) |
0.2 | 2.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.4 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 6.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 2.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 1.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 2.6 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 2.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 5.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 1.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 11.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.8 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 7.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 4.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.4 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 2.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0090537 | CERF complex(GO:0090537) |
0.1 | 2.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 13.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 5.0 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 4.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 0.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 2.7 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.7 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 4.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 11.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 9.8 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 14.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 1.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 22.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 1.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 4.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 1.9 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.7 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.7 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 3.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 1.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.6 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 6.4 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 1.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 3.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 3.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 1.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 2.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 2.2 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 2.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0036019 | endolysosome(GO:0036019) |
0.0 | 0.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.7 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.2 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.2 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.4 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 30.7 | GO:0031720 | haptoglobin binding(GO:0031720) hemoglobin alpha binding(GO:0031721) |
6.8 | 20.4 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
3.6 | 14.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.0 | 17.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.9 | 8.6 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
2.8 | 11.3 | GO:0048030 | disaccharide binding(GO:0048030) |
2.5 | 24.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
2.5 | 22.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.4 | 9.7 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
2.3 | 7.0 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.2 | 10.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
2.0 | 18.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.0 | 6.0 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
1.9 | 5.8 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
1.9 | 5.8 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
1.7 | 5.2 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
1.7 | 6.9 | GO:0003883 | CTP synthase activity(GO:0003883) |
1.6 | 8.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.6 | 6.5 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
1.6 | 4.8 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
1.5 | 9.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.5 | 7.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.4 | 10.1 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.4 | 4.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.4 | 4.2 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
1.4 | 69.6 | GO:0003785 | actin monomer binding(GO:0003785) |
1.4 | 6.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.4 | 12.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.3 | 8.1 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
1.3 | 4.0 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
1.3 | 4.0 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
1.3 | 9.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.3 | 12.8 | GO:0031014 | troponin T binding(GO:0031014) |
1.3 | 17.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.3 | 3.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.2 | 3.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.2 | 3.6 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
1.2 | 7.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.1 | 20.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.1 | 3.3 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.1 | 5.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.1 | 21.2 | GO:0044548 | S100 protein binding(GO:0044548) |
1.0 | 3.0 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.0 | 31.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.0 | 2.9 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
1.0 | 8.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.0 | 85.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.9 | 2.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.9 | 10.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.9 | 8.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.9 | 5.6 | GO:0044020 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.9 | 8.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.9 | 11.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.9 | 2.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.9 | 2.6 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.9 | 6.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.9 | 15.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.9 | 3.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.9 | 9.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.8 | 3.4 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.8 | 5.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.8 | 2.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.8 | 4.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.8 | 4.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.8 | 11.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.8 | 2.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.8 | 5.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.8 | 4.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.7 | 4.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 2.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.7 | 10.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.7 | 3.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.7 | 8.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.7 | 2.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 2.6 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.6 | 3.9 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.6 | 2.5 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.6 | 1.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.6 | 9.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 4.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.6 | 1.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.6 | 21.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.6 | 5.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 2.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.6 | 8.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.6 | 2.8 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.6 | 12.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.6 | 0.6 | GO:0070401 | NADP+ binding(GO:0070401) |
0.6 | 5.5 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.6 | 8.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.6 | 1.7 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.6 | 1.7 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.5 | 4.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 3.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 4.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 2.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 3.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 3.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 1.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 2.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 1.5 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.5 | 2.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.5 | 1.4 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.5 | 15.7 | GO:0019956 | chemokine binding(GO:0019956) |
0.5 | 7.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 1.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.5 | 7.9 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 3.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 5.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 1.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 1.3 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.4 | 3.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.4 | 1.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 2.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 4.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 2.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 1.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 1.2 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.4 | 11.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.4 | 1.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 2.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.4 | 2.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.4 | 1.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 5.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 1.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.4 | 5.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 6.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 2.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 12.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.4 | 1.5 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.4 | 6.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 5.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 1.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 5.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 2.5 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 21.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 1.4 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 2.8 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.3 | 1.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.3 | 2.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 3.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 2.0 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.3 | 1.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.4 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.3 | 2.0 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 1.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.3 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.3 | 3.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 2.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 1.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 11.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 9.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 2.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 1.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 3.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.3 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.3 | 2.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 2.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 2.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 3.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 3.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 1.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.3 | 3.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 1.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 4.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 2.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.0 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.3 | 1.0 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.3 | 1.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 1.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 1.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 6.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.7 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.2 | 1.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
0.2 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 2.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 11.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 7.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 6.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 28.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.9 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.2 | 8.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 4.4 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 0.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.2 | 1.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 37.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 26.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 1.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 2.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 1.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.2 | 3.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 5.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 9.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 23.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 1.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 0.9 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.2 | 2.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 0.2 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.2 | 0.7 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 14.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 3.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 4.0 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 1.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 1.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 5.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 6.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 3.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 8.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 32.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 2.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 6.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 1.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 1.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.2 | 3.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 5.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.6 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 0.6 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.1 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 2.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 6.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 4.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 1.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 1.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 1.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 2.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 7.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 2.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.5 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 2.6 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.1 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 3.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 5.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 2.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 8.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 2.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.9 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 1.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 2.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 1.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 2.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.7 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.2 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.1 | 0.5 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.4 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
0.1 | 4.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 0.2 | GO:0042979 | ornithine decarboxylase activator activity(GO:0042978) ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 2.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 2.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 5.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 2.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.2 | GO:0070122 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.0 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 4.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 9.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 3.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 10.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.1 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.1 | 1.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 1.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 3.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 1.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 1.8 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.8 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 24.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 4.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 1.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 3.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 1.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.2 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.0 | 0.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 1.1 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 2.0 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.0 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.0 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 24.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.0 | 22.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.9 | 17.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 6.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 31.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 23.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 4.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 9.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 9.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 2.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 6.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 8.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 36.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 4.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 4.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 11.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 17.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 18.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 17.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 2.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 15.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 4.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 6.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 24.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 6.2 | PID ATM PATHWAY | ATM pathway |
0.2 | 3.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 4.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 9.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 11.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 0.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 10.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 17.7 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 4.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 9.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 14.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 5.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 4.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 3.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 4.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 3.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 6.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 5.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 8.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 2.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 4.9 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 9.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 2.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 2.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 3.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 3.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 4.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 5.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 3.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 10.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.6 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 2.6 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
1.3 | 16.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.3 | 30.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.0 | 6.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.9 | 26.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 45.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.8 | 17.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.7 | 14.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.6 | 31.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 15.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 10.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 4.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 7.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 7.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 7.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 15.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.5 | 9.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.5 | 10.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 12.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.5 | 8.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 13.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.5 | 3.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 7.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.4 | 7.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 53.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 4.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 1.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.4 | 3.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 9.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 6.8 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.4 | 24.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 19.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 16.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 11.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 7.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 23.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 5.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 9.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 1.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 4.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 7.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 3.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 3.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 3.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 2.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 5.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 4.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 2.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 14.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 4.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 1.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 8.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 14.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 5.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 5.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 1.7 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 1.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 6.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 5.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 15.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 12.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 6.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 6.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 3.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 2.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 2.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 4.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 5.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 4.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 5.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 7.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 3.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.0 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 3.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 10.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 14.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 11.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 4.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 2.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 1.0 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |